Triple-negative breast carcinoma Clinical Trials

Delta Trials tracks 80 clinical trials for Triple-negative breast carcinoma in its publicly accessible dataset. Among the listed trials, 9 open for participant enrollment and 32 trials have reached completion. This research is carried out at 979 clinical sites around the world. An additional 39 trials have active registrations outside the recruiting and completed categories. Since 2020, 15 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.